Comparison of Amino Acid Positron Emission Tomographic Radiotracers for Molecular Imaging of Primary and Metastatic Brain Tumors
Molecular Imaging · 01.08.2014 · 13 (6)
DOI: 10.2310/7290.2014.00015 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Molecular Imaging, online erschienen am 01.08.2014. Verfasst von Csaba Juhász und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Radiopharmaceuticals. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Positron emission tomography (PET) is an imaging technology that can detect and characterize tumors based on their molecular and biochemical properties, such as altered glucose, nucleoside, or amino acid metabolism. PET plays a significant role in the diagnosis, prognostication, and treatment of various cancers, including brain tumors. In this article, we compare uptake mechanisms and the clinical performance of the amino acid PET radiotracers (L-[methyl- 11 C]methionine [MET], 18 F-fluoroethyl-tyrosine [FET], 18 F-fluoro-L- dihydroxy-phenylalanine [FDOPA], and 11 C-alpha-methyl-L-tryptophan [AMT]) most commonly used for brain tumor imaging. First, we discuss and compare the mechanisms of tumoral transport and accumulation, the basis of differential performance of these radioligands in clinical studies. Then we summarize studies that provided direct comparisons among these amino acid tracers and to clinically used 2-deoxy-2[ 18 F]fluoro-D-glucose [FDG] PET imaging. We also discuss how tracer kinetic analysis can enhance the clinical information obtained from amino acid PET images. We discuss both similarities and differences in potential clinical value for each radioligand. This comparative review can guide which radiotracer to favor in future clinical trials aimed at defining the role of these molecular imaging modalities in the clinical management of brain tumor patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- NCI NIH HHS
Zitieren
APA
Juhász, C., Dwivedi, S., Kamson, D. O., Michelhaugh, S. K., & Mittal, S. (2014). Comparison of Amino Acid Positron Emission Tomographic Radiotracers for Molecular Imaging of Primary and Metastatic Brain Tumors. Molecular Imaging, 13(6). https://doi.org/10.2310/7290.2014.00015
Vancouver
Juhász C, Dwivedi S, Kamson DO, Michelhaugh SK, Mittal S. Comparison of Amino Acid Positron Emission Tomographic Radiotracers for Molecular Imaging of Primary and Metastatic Brain Tumors. Molecular Imaging. 2014;13(6). doi:10.2310/7290.2014.00015
BibTeX
@article{Juhsz2014,
author = {Juhász, Csaba and Dwivedi, Shalini and Kamson, David O and Michelhaugh, Sharon K and Mittal, Sandeep},
title = {Comparison of Amino Acid Positron Emission Tomographic Radiotracers for Molecular Imaging of Primary and Metastatic Brain Tumors},
journal = {Molecular Imaging},
year = {2014},
volume = {13},
number = {6},
doi = {10.2310/7290.2014.00015}
}
EUVIMED